Skip to main content

Advertisement

Fig. 1 | Chinese Journal of Cancer

Fig. 1

From: Weekly taxane–anthracycline combination regimen versus tri-weekly anthracycline-based regimen for the treatment of locally advanced breast cancer: a randomized controlled trial

Fig. 1

Study flow chart for comparison of weekly PE and tri-weekly FEC regimens in treating locally advanced breast cancer. FEC tri-weekly 5-fluorouracil–epirubicin–cyclophosphamide regimen, PE weekly paclitaxel–epirubicin regimen, NACT neoadjuvant chemotherapy. #All participants who switched chemotherapy regimens had undergone surgery except one in the PE arm that was lost to follow-up

Back to article page